UJ-30

N/A

Report date: 2025/01/26 15:57:28
NME

Base Information

Drug NameUJ-30
Drug Alias Nametyrosine kinase inhibitor (University of Zürich)UJ-30
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine kinases inhibitors
TargetsProtein-tyrosine kinases
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Zurich
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Zurich
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A